MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Clinical Outcome Assessments for Psychiatric Manifestations in Dystonia: Systematic Review, Critique, and Recommendations

A. Wagle Shukla, K. Peall, D. Martino, G. Chan, S. Pandey, S. Rafee, V. Voros, M. Tijssen, N. Kovacs, M. Skorvanek (Gainesville, USA)

Meeting: 2026 International Congress

Keywords: Anxiety, Dystonia: Clinical features, Scales

Category: Dystonia: Epidemiology, phenomenology, clinical assessment, rating scales

Objective: An International Parkinson and Movement Disorder Society subcommittee aimed to assess the quality of severity and screening instruments for depression, anxiety, apathy, OCD, mania, psychotic features, and personality profiles in dystonia.

Background: Psychiatric disorders, particularly depression and anxiety, are highly prevalent in patients with dystonia; however, it remains unclear whether appropriate clinical outcome assessment (COA) tools are available for clinicians and researchers.

Method: Following the methodology adopted by previous International Parkinson and Movement Disorder Society subcommittee papers, instruments used to assess psychiatric constructs in dystonia were reviewed and classified as “recommended,” “recommended with caveats,” “suggested,” or “listed.”

Results: Our review identified 29 COAs. The highest level which is “recommended” was assigned to three instruments: the Beck Anxiety Inventory, Hospital Anxiety and Depression Scale, and TWSTRS-Psych. Eight instruments were classified as “recommended with caveats,” including the Beck Depression Inventory, Montgomery–Åsberg Depression Rating Scale, Hamilton Depression Rating Scale, Hamilton Anxiety Scale, State–Trait Anxiety Inventory, Liebowitz Social Anxiety Scale, Yale–Brown Obsessive Compulsive Scale, and the Dystonia Non-Motor Screening Tool. The main limitations include absence of dystonia-specific cut-off values; limited evidence for reliability metrics (e.g., test–retest reliability); insufficient evaluation of validity (e.g., known-groups and divergent validity); and limited evidence of responsiveness to change, particularly the minimum clinically meaningful change. The remaining were classified as “suggested”.

Conclusion: The high number of instruments “recommended with caveats” does not support developing new instruments for assessing psychiatric constructs in dystonia. However, addressing these caveats through new psychometric studies and revising existing instruments to improve nomenclature clarity are recommended next steps.

To cite this abstract in AMA style:

A. Wagle Shukla, K. Peall, D. Martino, G. Chan, S. Pandey, S. Rafee, V. Voros, M. Tijssen, N. Kovacs, M. Skorvanek. Clinical Outcome Assessments for Psychiatric Manifestations in Dystonia: Systematic Review, Critique, and Recommendations [abstract]. Mov Disord. 2026; 41 (suppl 1). https://www.mdsabstracts.org/abstract/clinical-outcome-assessments-for-psychiatric-manifestations-in-dystonia-systematic-review-critique-and-recommendations/. Accessed October 1, 2026.
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to 2026 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/clinical-outcome-assessments-for-psychiatric-manifestations-in-dystonia-systematic-review-critique-and-recommendations/

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley